Literature DB >> 1838395

System analysis in multiple dose kinetics: evidence for saturable tubular reabsorption of the organic cation N1-methylnicotinamide in humans.

W Weber1, S Toussaint, M Looby, M Nitz, H Kewitz.   

Abstract

The renal clearance of N1-methylnicotinamide (NMN) was studied in 8 young women at physiological steady state and at steady state following a combined loading bolus and iv infusion. Urinary NMN concentrations were determined using a new HPLC method, plasma levels by a conventional fluorescence method. At physiological levels net tubular secretion of NMN was evident due to a renal fractional excretion, i.e., a ratio of renal NMN clearance to creatinine clearance, above unity. Increasing plasma concentrations lead to an increase in the fractional excretion, indicating saturation of the underlying tubular reabsorption process. Binding to plasma proteins was excluded by ultra-filtration experiments. Clearances measured at physiological levels were about one half of the maximum renal clearance attained following the infusion. This maximum value was approximately six times the creatinine clearance and may be a useful approximation of the renal plasma flow. System analysis, including a novel method to calculate the net response following a multiple input, was used to determine the pharmacokinetic system parameters.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1838395     DOI: 10.1007/bf01062963

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  19 in total

1.  Studies on the renal tubular secretion of N1-methylnicotinamide.

Authors:  A FARAH; M FRAZER
Journal:  J Pharmacol Exp Ther       Date:  1961-11       Impact factor: 4.030

2.  The fate of N1-methylnicotinamide in man.

Authors:  W A PERLZWEIG; J W HUFF
Journal:  J Biol Chem       Date:  1945       Impact factor: 5.157

3.  Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

4.  Preparation of mean drug concentration--time curves in plasma. A study on the frequency distribution of pharmacokinetic parameters.

Authors:  E Mizuta; A Tsubotani
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-04       Impact factor: 1.645

5.  Analysis of pharmacokinetic data using parametric models. II. Point estimates of an individual's parameters.

Authors:  L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1985-10

6.  Fluorometric quantitation of picomole amounts of 1-methylnicotinamide and nicotinamide in serum.

Authors:  B R Clark
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  N1-methylnicotinamide transport by isolated perfused snake proximal renal tubules.

Authors:  W H Dantzler; O H Brokl
Journal:  Am J Physiol       Date:  1986-03

8.  Estimation of renal blood flow by use of endogenous N1-methylnicotinamide in rats.

Authors:  C K Shim; Y Sawada; T Iga; M Hanano
Journal:  J Pharmacobiodyn       Date:  1985-01

9.  Determination of thiamine in human plasma and its pharmacokinetics.

Authors:  W Weber; H Kewitz
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

10.  Transport of the organic cation N1-methylnicotinamide by the rabbit proximal tubule. II. Reabsorption and secretion in the isolated perfused tubule.

Authors:  K Besseghir; J Y Chatton; F Roch-Ramel
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

View more
  6 in total

1.  Urinary excretion: does it accurately reflect relative differences in bioavailability/systemic exposure when renal clearance is nonlinear?

Authors:  Gary A Thompson; Roger D Toothaker
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

2.  Evaluation of hepatic function using the pharmacokinetics of a therapeutically administered drug. Application to the immunosuppressant cyclosporin.

Authors:  W Weber; M Looby; J Brockmöller
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

3.  Pregnancy Increases the Renal Secretion of N1-methylnicotinamide, an Endogenous Probe for Renal Cation Transporters, in Patients Prescribed Metformin.

Authors:  Mackenzie C Bergagnini-Kolev; Mary F Hebert; Thomas R Easterling; Yvonne S Lin
Journal:  Drug Metab Dispos       Date:  2017-01-09       Impact factor: 3.922

Review 4.  Nonlinear kinetics and the 1-exp function in nephropharmacology.

Authors:  F Keller; K Erdmann; M Giehl
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.

Authors:  Fabian Müller; Constanza A Pontones; Bertold Renner; Maren Mieth; Eva Hoier; Daniel Auge; Renke Maas; Oliver Zolk; Martin F Fromm
Journal:  Eur J Clin Pharmacol       Date:  2014-10-22       Impact factor: 2.953

Review 6.  Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation.

Authors:  Yang Li; Zahra Talebi; Xihui Chen; Alex Sparreboom; Shuiying Hu
Journal:  Molecules       Date:  2021-09-10       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.